{"id":"W2115499099","doi":"10.1093/jnci/djp079","title":"Dose Escalation Methods in Phase I Cancer Clinical Trials","year":2009,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":861,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Fondation de France","keywords":"Clinical trial; Medicine; Clinical endpoint; Maximum tolerated dose; Phases of clinical research; Drug; Surrogate endpoint; Pharmacology; Oncology; Drug development; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05615478,0.001645376,0.00344403,0.003406996,0.0002901199,0.001970982,0.002911402,0.001449616,0.003839913],"category_scores_gemma":[0.104972,0.0008761557,0.002370764,0.003794861,0.002578513,0.001872565,0.001549193,0.005478716,0.001684164],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002096019,"about_ca_system_score_gemma":0.003864562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004841558,"about_ca_topic_score_gemma":0.0004693788,"domain_scores_codex":[0.9443575,0.04380819,0.003502785,0.001581536,0.006542708,0.0002072181],"domain_scores_gemma":[0.8993792,0.0864977,0.006637951,0.003881556,0.003251662,0.0003518492],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003797091,0.0001050733,0.0004066243,0.01591721,0.0008602172,0.00003843039,0.0001472078,0.008832602,0.0005199668,0.0333194,0.01277038,0.9267031],"study_design_scores_gemma":[0.00306674,0.002893656,0.004479916,0.03110537,0.002711107,0.001657816,0.0002422119,0.03449866,0.005895419,0.2747669,0.6384243,0.0002578819],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001244209,0.5660234,0.4129408,0.004207243,0.00163595,0.004221859,0.0003954674,0.0007339843,0.008597218],"genre_scores_gemma":[0.03312354,0.4731533,0.469949,0.003608933,0.002119901,0.01391918,0.0005992948,0.0003860646,0.003140858],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9438452,"threshold_uncertainty_score":0.2969785,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.9534115106481834,"score_gpt":0.8140813552163118,"score_spread":0.1393301554318717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}